A Pilot Randomized Controlled Trial Assessing the Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression

What this Trial Is About

Researchers are studying Group Medical Visits (GMVs) to see if they are practical and well-received by adults with depression and anxiety. This pilot randomized controlled trial aims to gather early information on whether GMVs can reduce depression and anxiety symptoms, which will help design a larger future study. The main focus is to find out if patients find GMVs feasible and acceptable as part of their mental health care. Participants are randomly placed into one of two groups: one receives GMVs every two weeks for six months via virtual meetings, where they participate in group discussions, psychoeducation, and medication follow-ups, including brief individual check-ins. The other group receives standard care, which includes follow-up with their primary care provider, possible individual psychiatric care, and referrals to therapy groups if needed. Throughout the study, participants will complete questionnaires evaluating satisfaction with care, depression and anxiety levels, recovery, and quality of life at different points, including before and during the intervention at months 3 and 6. The study will also track recruitment, retention, and satisfaction of primary care providers. Participation involves virtual sessions and assessments over approximately nine months, with safety and effectiveness monitored throughout.

Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression